These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recent acquisitions in acquired and congenital von Willebrand disorders. Franchini M; Lippi G Clin Chim Acta; 2007 Feb; 377(1-2):62-9. PubMed ID: 17140556 [TBL] [Abstract][Full Text] [Related]
8. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Federici AB Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707 [TBL] [Abstract][Full Text] [Related]
9. Advances in hematology. Etiology and diagnosis of acquired von Willebrand syndrome. Franchini M; Lippi G; Favaloro EJ Clin Adv Hematol Oncol; 2010 Jan; 8(1):20-4. PubMed ID: 20351678 [No Abstract] [Full Text] [Related]
10. Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia. Rolf N; Suttorp M; Budde U; Siegert G; Knoefler R Thromb Haemost; 2010 Jun; 103(6):1272-4. PubMed ID: 20352170 [No Abstract] [Full Text] [Related]
11. Acquired von Willebrand syndrome: from pathophysiology to management. Veyradier A; Jenkins CS; Fressinaud E; Meyer D Thromb Haemost; 2000 Aug; 84(2):175-82. PubMed ID: 10959686 [No Abstract] [Full Text] [Related]
12. Diagnosis and management of acquired von Willebrand syndrome. Federici AB; Mannucci PM Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand Syndrome. Mital A Adv Clin Exp Med; 2016; 25(6):1337-1344. PubMed ID: 28028990 [TBL] [Abstract][Full Text] [Related]
14. Acquired von Willebrand syndrome: features and management. Mohri H Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821 [TBL] [Abstract][Full Text] [Related]
15. Current approaches to pregnancy and childbirth in women with von Willebrand disease. Johnsen JM Clin Adv Hematol Oncol; 2018 Apr; 16(4):254-257. PubMed ID: 29742079 [No Abstract] [Full Text] [Related]
16. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options. Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130 [TBL] [Abstract][Full Text] [Related]
17. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease. van Genderen PJ; Terpstra W; Michiels JJ; Kapteijn L; van Vliet HH Thromb Haemost; 1995 May; 73(5):891-2. PubMed ID: 7482422 [No Abstract] [Full Text] [Related]
18. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Sucker C; Michiels JJ; Zotz RB Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364 [TBL] [Abstract][Full Text] [Related]
19. [Von Willebrand disease: a common and unrecognized bleeding disorder]. Boehlen F; Robert-Ebadi H; de Moerloose P Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733 [TBL] [Abstract][Full Text] [Related]
20. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies. Favaloro EJ Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]